News

Teva news, press releases, and media contact information

Press Releases
Keyword Search
 
  
For all global news, visit our corporate site.
09/28/2016Teva Announces Launch of Generic Epzicom® Tablets in the United StatesJERUSALEM--(BUSINESS WIRE)--Sep. 29, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of a ge... 
09/22/2016Teva Announces Positive Top-Line Data from Second Phase III Study of SD-809 in Tardive Dyskinesia (TD)SD-809 demonstrates a statistically significant improvement in Abnormal Involuntary Movement Scale score in AIM-TD study Adds ... 
09/20/2016Teva and Regeneron Announce Global Collaboration to Develop and Commercialize Fasinumab, an Investigational NGF Antibody for Chronic PainNovel Nerve Growth Factor (NGF) Antibody Has Potential to Address Limitations of Current Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) ... 
09/15/2016National Business Group on Health Honors Teva Pharmaceuticals Teva Pharmaceuticals Recognized for One of the Nation’s Best Workforce Well-being Programs. North Wales, PA, September 15, 2016 – Teva Pharmaceutic... 
09/15/2016Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin® (Daptomycin for Injection) in the United StatesJERUSALEM--(BUSINESS WIRE)--Sep. 15, 2016-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced the launch of an a... 
09/06/2016Teva to Present at the Wells Fargo 2016 Healthcare ConferenceJERUSALEM--(BUSINESS WIRE)--Sep. 6, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Wells ... 
08/29/2016Teva to Host Generic Medicines Business Overview on September 9, 2016JERUSALEM--(BUSINESS WIRE)--Aug. 29, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will host a confere... 
08/05/2016Teva Announces Launch of Generic Gleevec® Tablets in the United StatesJERUSALEM--(BUSINESS WIRE)--Aug. 5, 2016-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced the launch of the g... 
08/04/2016Teva Reports Second Quarter 2016 ResultsJERUSALEM--(BUSINESS WIRE)--Aug. 4, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended... 
08/03/2016Teva Announces Acquisition of Anda Inc.Acquisition is a great strategic fit that will enable Teva and Anda to provide enhanced offerings to customers JERUSALEM--(BUSINESS ... 
08/02/2016Teva Completes Acquisition of Actavis GenericsAcquisition Reinforces Teva's Strategy and Opens New Possibilities for the Company in Generics and Specialty; Serving 250 Million People, ... 
07/27/2016Teva Receives Clearance from the U.S. Federal Trade Commission for Actavis Generics AcquisitionAcquisition Strongly Reinforces Teva's Strategy and Opens New Possibilities in Generics and Specialty Added Capabili... 
07/12/2016Teva to Host Conference Call and Webcast to Provide Preliminary Outlook for 2016-2019JERUSALEM--(BUSINESS WIRE)--Jul. 12, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will host ... 
07/05/2016Teva and the Huntington Study Group Announce Publication of Pivotal Phase III Data on Deutetrabenazine (SD-809) in Huntington Disease from First-HD Trial in JAMAJERUSALEM--(BUSINESS WIRE)--Jul. 5, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and the Huntington Study Group (HSG)... 
06/28/2016Teva Announces FDA Acceptance of New Drug Applications for Fluticasone Propionate/Salmeterol and Fluticasone Propionate RespiClick® InhalersTherapies Utilize Core Multi-Dose Dry Powder Inhaler Technology that Lowers Dosage and Eliminates Hand-Breath Coordination During Inha... 
06/27/2016Teva and Antares Pharma Announce Launch of Generic Imitrex® in the United StatesJERUSALEM & EWING, N.J.--(BUSINESS WIRE)--Jun. 27, 2016-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) and Antares Pharma,... 
06/24/2016Teva Receives CHMP Positive Opinion for CINQAERO® (reslizumab)Add-On Therapy Targeting IL-5 in Adults with Severe Eosinophilic Asthma Pending Marketing Authorization in Europe JERUSALEM--(BUSINE... 
06/23/2016Teva Settles Patent Litigation with AstraZeneca Allowing Teva to Commercialize Its Generic Version of Byetta® (Exenatide Injection) in the United StatesJERUSALEM--(BUSINESS WIRE)--Jun. 23, 2016-- Teva Pharmaceuticals USA, Inc., (NYSE and TASE:TEVA) today announced that they have settled ... 
06/13/2016Teva Announces Voluntary Suspension of Marketing for ZECUITY® in the U.S.Teva is working closely with the U.S. Food and Drug Administration to further analyze reports of adverse skin reactions and investigate root ... 
06/10/2016Teva Announces Favorable Court Ruling in TREANDA® (bendamustine hydrochloride) Patent Infringement LitigationJERUSALEM--(BUSINESS WIRE)--Jun. 10, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the United St... 
06/07/2016Teva Gains Recommendation for Approval from FDA Advisory Committees for VANTRELA™ ER (hydrocodone bitartrate) Extended-Release Tablets CII Formulated with Proprietary Abuse Deterrence TechnologyCommittees voted that if approved, VANTRELA ER should be labeled as an abuse-deterrent product by the oral, nasal, and intravenous routes of ... 
06/07/2016Teva to Present at the Jefferies 2016 Healthcare ConferenceJERUSALEM--(BUSINESS WIRE)--Jun. 7, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Jeffer... 
06/06/2016Teva to Present at the Goldman Sachs 37th Annual Global Healthcare ConferenceJERUSALEM--(BUSINESS WIRE)--Jun. 6, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Goldman... 
05/31/2016Teva to Present at the Bernstein 32nd Annual Strategic Decisions ConferenceJERUSALEM--(BUSINESS WIRE)--May 31, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Bernste... 
05/31/2016Teva Receives Complete Response Letter for NDA for SD-809 for the Treatment of Chorea Associated with Huntington DiseaseJERUSALEM--(BUSINESS WIRE)--May 31, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced that it has received... 
05/12/2016Teva to Present New Data at the 2016 American Thoracic Society (ATS) International ConferencePresentations Highlight New Results for Two Asthma Therapies – CINQAIR® (reslizumab) Injection and ProAir RespiClick® (albuterol sulfate... 
05/09/2016Teva to Present at the Bank of America Merrill Lynch 2016 Health Care ConferenceJERUSALEM--(BUSINESS WIRE)--May 9, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Bank of ... 
05/09/2016Teva Reports First Quarter 2016 ResultsJERUSALEM--(BUSINESS WIRE)--May 9, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today reported results for the quarter ended ... 
05/04/2016Teva Breathes Its Way to a Guinness World Records TitleAMSTERDAM, May 4, 2016 /PRNewswire/ -- What can you do in 30 minutes? Catch up on your favourite sitcom? Burn 180 calories on an exercise bike? Cle... 
04/29/2016Teva Announces FDA Approval of ProAir RespiClick® (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11New Pediatric Indication Provides Treatment Option for Children that Eliminates Need for Spacer and Hand-Breath Coordination During Inhalation ... 
04/25/2016Jennifer Morrison Reveals How Her Journey with Migraine is More Than a HeadacheActress Shares Her Migraine Experience as Part of MoreToMigraine.com FRAZER, Pa.--(BUSINESS WIRE)--Apr. 25, 2016-- Teva Pharmaceutic... 
04/18/2016Teva to Report First Quarter 2016 Financial Results on May 9, 2016JERUSALEM--(BUSINESS WIRE)--Apr. 18, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will release its fi... 
04/18/2016Teva Presents New Data for SD-809 in Huntington Disease at 68th American Academy of Neurology (AAN) Annual Meeting in Vancouver, B.C.First-HD Study shows improvements in Total Motor Score and Swallowing Function in Huntington disease patients treated with SD-809 JE... 
04/12/2016Teva to Present Data Highlighting Company’s Pipeline in Neurological Disorders at 68th AAN Annual MeetingData in Huntington disease, multiple sclerosis, Tourette syndrome and migraine to be presented JERUSALEM--(BUSINESS WIRE)--Apr. 12, ... 
03/23/2016Teva Announces FDA Approval of CINQAIR® (reslizumab) InjectionNew Biologic for Add-On Maintenance Treatment in Adults with Severe Asthma and an Eosinophilic Phenotype JERUSALEM--(BUSINESS WIRE)-... 
03/22/2016Teva Announces Launch of Generic Campral® in the United StatesJERUSALEM--(BUSINESS WIRE)--Mar. 22, 2016-- Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced the launch of the generic e... 
03/11/2016Teva to Present at the Barclays Global Healthcare ConferenceJERUSALEM--(BUSINESS WIRE)--Mar. 11, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) will host a live audio webcast at the Barcl... 
03/09/2016Teva Completes Generic Pulmicort® Respules Portfolio with the Launch of Third Strength in the United StatesJERUSALEM--(BUSINESS WIRE)--Mar. 9, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced the launch of the generic eq... 
03/03/2016Teva Completes Acquisition of RimsaTransaction Extends Teva’s Presence in Key Global Market and Enhances Growth Potential JERUSALEM--(BUSINESS WIRE)--Mar. 3, 2016-- ... 
03/03/2016Teva to Present New Respiratory Data at the 2016 Academy of Allergy, Asthma and Immunology Annual MeetingPositive Data Reported For Teva’s Targeted Biologic; and Pediatric Data on Breath-Actuated, Dry-Powder Short-Acting Beta-Agonist (SABA) ... 
03/02/2016Teva to Present at the Cowen & Company 36th Annual Healthcare ConferenceJERUSALEM--(BUSINESS WIRE)--Mar. 2, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the Cowen &... 
02/24/2016Teva Pharmaceuticals Embarks on Strategic Corporate Identity Program to Build a Global BrandJERUSALEM--(BUSINESS WIRE)--Feb. 24, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced that it is embarkin... 
02/11/2016Teva Files 2015 Annual Report on Form 20-FJERUSALEM--(BUSINESS WIRE)--Feb. 11, 2016-- In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, Teva... 
02/11/2016Teva Reports Full Year 2015 and Fourth Quarter Financial ResultsJERUSALEM--(BUSINESS WIRE)--Feb. 11, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today reported results for the year and the ... 
01/28/2016Teva Announces 2016 U.S. Community Partner Organizations... 
01/28/2016Teva and Eagle Pharmaceuticals Announce Commercial Availability of BENDEKA™ (bendamustine hydrochloride) InjectionJERUSALEM & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Jan. 28, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Eagle P... 
01/28/2016Teva to Report Fourth Quarter 2015 Financial Results on February 11, 2016JERUSALEM--(BUSINESS WIRE)--Jan. 28, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its fou... 
01/07/2016Teva and Checkpoint Therapeutics Announce License Agreement for Oral PARP InhibitorCheckpoint to Obtain Exclusive Worldwide Development and Commercialization Rights JERUSALEM & NEW YORK--(BUSINESS WIRE)--Jan. 7, 201... 
01/07/2016Teva to Present at the 34th Annual J.P. Morgan Healthcare ConferenceJERUSALEM--(BUSINESS WIRE)--Jan. 7, 2016-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the 34th An... 
01/05/2016Teva Announces Launch of Generic Ortho Tri-Cyclen® Lo in the United StatesJERUSALEM--(BUSINESS WIRE)--Jan. 5, 2016-- Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) announced the launch of a generic equivalent... 
  Teva Stories
06/20/2016
Teva CEO Erez Vigodman speaks at 2016 SelectUSA Investment Summit
On June 20 at the 2016 SelectUSA Investment Summit in Washington D.C., Erez Vigodman, President & CEO, Teva Pharmaceuticals, spoke to investors, representatives of U.S. economic development organizations, U.S. state and local governments officials and others, about Teva’s critical role in delivering value to the U.S. healthcare system and economy.
Biography Photo
04/01/2016
Teva takes on a tornado
When a natural disaster struck in Virginia, Teva employees didn’t wait to be asked—they jumped up to help.
Biography Photo
03/02/2016
Teva’s Community Partnership Program: Making an Impact Together in 2016
This exciting Teva program provides charitable funding and employee volunteers to qualified local organizations that support patients and their caregivers in geographic areas where Teva has business presence.
Biography Photo
12/14/2015
Rolling up our sleeves to help kids get wheels
We’re known for making medicines at Teva. And lately, we’ve also been building…bicycles? Here’s why.
Biography Photo
11/06/2015
TAPI Vice President named to leading industry board
We know our Teva leaders have unmatched expertise—and our industry associations recognize it too. The Drug, Chemical & Associated Technology Association named Kerri McCullough Wood, VP and Head of Global TAPI sales, to their Board of Directors this fall.
Biography Photo
10/23/2015
Homeless but not friendless: Teva's Cincinnati women help homeless young adults
On Tuesday, October 13, the Women@Teva Employee Resource Group's Community Outreach team had their first event at Lighthouse Youth Services and The Sheakley Center in Cincinnati, Ohio. Nineteen women volunteered their time to serve homeless young adults ranging in age from 18-24.
Biography Photo
10/14/2015
Rutgers and Teva Join Forces in Support of Pharmaceutical Industry Fellowship Program
Teva Regulatory Affairs is excited to be part of the Pharmaceutical Industry Fellowship Program at Rutgers University. We believe Teva offers a unique opportunity to gain experience in both generic and branded regulatory affairs in our facilities located in the suburban Philadelphia area.
Biography Photo
09/10/2015
Teva Announces Newly Named Grant Program and 2015 Awardees at Boston Symposium
Teva recognizes that great medicines begin with great science. Teva has re-established the Teva Pharmaceutical Scholars Grant Program, now known as the Teva Pharmaceuticals Marc A. Goshko Memorial Grant Program.
Biography Photo
09/09/2015
Call for Entries! Apply for Teva's 2016 Community Partnership Program
Each year, Teva selects patient- and caregiver-focused organizations in areas where we have a significant business presence to be part of our Community Partnership program. These organizations receive a charitable donation from Teva, and they provide volunteer opportunities for our employees in those regions.
Biography Photo
07/13/2015
Summer showers honors on US Generics
At Teva, we try to make a difference and improve access to good health care every day. In June and July, Teva was honored with two major industry awards for doing just that.
Biography Photo
06/17/2015
Pride Month at Teva
Our Pride Month theme is “The Courage to Be.” It’s a way of saying that we at Teva welcome everyone and stand for full self-expression in the workplace.
Biography Photo
05/21/2015
Teva takes steps to fight hate
Teva is committed to promoting a more diverse and inclusive society—not only within our organization but throughout the communities where we live and work—and we’re taking (literal) steps to show it!
Biography Photo
05/15/2015
Michelle Cuccia recognized during HBA Rising Star luncheon
On May 14, Teva’s own Michelle Cuccia, Marketing Vice President – Growth Markets, was honored at the annual Healthcare Businesswomen’s Association (HBA) Woman of the Year luncheon.
Biography Photo
05/11/2015
Teva’s Northeast Pain Care Team brings fun to kids
Sometimes you never know where you’ll find the path to help make people’s lives better.
Biography Photo